Enhanced Recovery After Surgery in Cytoreductive Surgery With HIPEC: Implementation and Outcomes From a High‐Volume Tertiary Centre in a Lower‐Middle Income Country | Synapse
April 10, 2026
Enhanced Recovery After Surgery in Cytoreductive Surgery With HIPEC: Implementation and Outcomes From a High‐Volume Tertiary Centre in a Lower‐Middle Income Country
Puntos clave
To evaluate the feasibility and safety of an Enhanced Recovery After Surgery (ERAS) pathway for cytoreductive surgery with HIPEC in a lower-middle income country.
Implemented the ERAS pathway for CRS-HIPEC procedures.
Conducted the study in a high-volume tertiary center.
Monitored hospital stay duration, morbidity, and mortality rates.
Patients experienced shorter hospital stays after surgery.
The ERAS pathway did not increase morbidity or mortality rates.
Implementation was deemed feasible and safe in the local context.
Resumen
Implementation of an ERAS pathway for CRS-HIPEC in a high-volume LMIC centre is feasible and safe, resulting in shorter hospital stay without increasing morbidity or mortality.